Task of Acoustic-phonetic Decoding on Anatomic Deficits in Paramedical Assessment of Speech Disorders for Patients Treated for Oral or Oropharyngeal Cancer

NCT ID: NCT04742998

Last Updated: 2023-07-24

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 116 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2021-10-22
• Study Completion Date: 2024-10-22

Brief Summary

The bridging of the gap between speech production and perception by the interlocutor would be made possible by the use of a more suitable and automatic task. An acoustic-phonetic decoding test (or DAP in French, i.e. the production of isolated pseudo-words in repetition or reading), created within the framework of the The French National Cancer Institute (InCA) C2SI project, avoids the effects of cognitive restoration by the interlocutor. An automatic score from the DAP would lead to an overall score per patient, but also to scores specific to each phonetic segment, to be correlated with the analytical scores from each anatomical oropharyngeal segment.

The study hypothesis is that the automatic processing of an acoustic-phonetic decoding task during the assessment in current practice is a valid and reliable tool for diagnosing oropharyngeal analytical and dynamic deficits by highlighting deficient linguistic units.

The study hypothesis is that the automatic processing of an acoustico-phonetic decoding task during the assessment in current practice is a tool for diagnosing oropharyngeal analytical and dynamic deficits by highlighting deficient linguistic units.

Detailed Description

Fifth cancer in terms of incidence in France, tumor pathologies of the upper aero-digestive tract, due to their location, impact the speech abilities of affected subjects. Speech therapy in paramedical clinical assessments consist of two parts.

• The analytical part to highlight the anatomical and dynamic deficits of segments involved in speech.
• The functional part characterizes the pathophysiological impact by means of an "ear" assessment.

The link between anatomy and functional speech deficit is very close in oncology (the location and the size of the tumor, the structural changes due to the treatment who modify the oropharyngeal dynamics and the mechanisms involved in the production of the speech), but the correlation is weak between functional intelligibility scores and analytical motor scores. Indeed, the perception of speech by a human listener is not a simple "recording" of the production, but a representation of this production after implementation of individual mechanisms for restoring the acoustic information linked to the lexicon or to the context by the listener. The listener's degree of familiarity with the speaker or his pathology is also a source of variability.

The bridging of the gap between speech production and perception by the interlocutor would be made possible by the use of a more suitable and automatic task. An acoustic-phonetic decoding test (or DAP in French, i.e. the production of isolated pseudo-words in repetition or reading), created within the framework of the InCA C2SI project, avoids the effects of cognitive restoration by the interlocutor. An automatic score from the DAP would lead to an overall score per patient, but also to scores specific to each phonetic segment, to be correlated with the analytical scores from each anatomical oropharyngeal segment.

The study hypothesis is that the automatic processing of an acoustic-phonetic decoding task during the assessment in current practice is a valid and reliable tool for diagnosing oropharyngeal analytical and dynamic deficits by highlighting deficient linguistic units.

Conditions

Speech Intelligibility

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Study Groups

Patients treated for an oral or oropharyngeal tumor for at least 6 months

Patients treated for an oral or oropharyngeal tumor for at least 6 months

Acoustic-phonetic decoding task (DAP)

Intervention Type: OTHER

Completion of speech-related quality of life autoquestionnaires Routine speech assessment Acoustic-phonetic decoding task (DAP) two lists of 16 pseudo-words

Interventions

Acoustic-phonetic decoding task (DAP)

Completion of speech-related quality of life autoquestionnaires Routine speech assessment Acoustic-phonetic decoding task (DAP) two lists of 16 pseudo-words

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Patients aged at least 18 years old and benefiting from a social security scheme
• Native French-speaking patients
• Patients treated for cancer of the oral cavity or oropharynx (surgical and / or radiotherapy and / or chemotherapy treatment)
• Patients in clinical remission for at least 6 months (chronic nature and stability of the disorders)
• All tumor sizes according to the tumor (T), node (N), and metastasis (M) categories (TNM classification) (T1 to T4)
• Patients with a perceptible speech disorder in a conversational situation or not (to allow the determination of fine deficits)
• Patients who do not object to carrying out the research

Exclusion Criteria

• Patients with an associated pathology potentially responsible for speech or fluency disorders (joint, speech and language disorders of developmental, organic or functional origin, voice disorders of organic or functional origin, stammering , stammering, fluency disturbances, speech disturbances of neurological origin)
• Patients reporting an auditory complaint and not having a hearing aid
• Inability to provide the person with enlightened information and to ensure the subject's compliance because of impaired physical and / or psychological health,
• Patients participating in another research including an exclusion period still in progress.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Laboratoire parole et langage

UNKNOWN

Sponsor Role: collaborator

Laboratoire Information Avignon université

UNKNOWN

Sponsor Role: collaborator

IRIT - Institut de Recherche en Informatique de Toulouse

UNKNOWN

Sponsor Role: collaborator

University Hospital, Toulouse

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Clémence DEVOUCOUX

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse

Locations

AP- H Marseille - Hôpital de la Conception

Marseille, , France

Site Status: RECRUITING

Institut universitaire du Cancer de Toulouse - Oncopole

Toulouse, , France

Site Status: NOT_YET_RECRUITING

University Hospital Toulouse

Toulouse, , France

Site Status: RECRUITING

Countries

France

Central Contacts

Clémence DEVOUCOUX

Role: CONTACT

devoucoux.c@chu-toulouse.fr

06.50.72.24.85 ext. +33

Anaïs GALTIER

Role: CONTACT

Galtier.a@chu-toulouse.fr

05. 67. 77. 18 .70 ext. +33

Facility Contacts

Camille GALANT

Role: primary

camille.galant@ap-hm.fr

06 28 43 14 23

Pauline CHAUSSIER

Role: primary

chaussier.pauline@iuct-oncopole.fr

05 31 15 55 04

Clémence DEVOUCOUX

Role: primary

devoucoux.c@chu-toulouse.fr

06.50.72.24.85

References

Balaguer M, Farinas J, Fichaux-Bourin P, Puech M, Pinquier J, Woisard V. Validation of the French Versions of the Speech Handicap Index and the Phonation Handicap Index in Patients Treated for Cancer of the Oral Cavity or Oropharynx. Folia Phoniatr Logop. 2020;72(6):464-477. doi: 10.1159/000503448. Epub 2019 Nov 15.

Reference Type: BACKGROUND

PMID: 31734664 (View on PubMed)

Balaguer M, Champenois M, Farinas J, Pinquier J, Woisard V. The (head and neck) carcinologic handicap index: validation of a modular type questionnaire and its ability to prioritise patients' needs. Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1159-1169. doi: 10.1007/s00405-020-06201-6. Epub 2020 Jul 14.

Reference Type: BACKGROUND

PMID: 32666294 (View on PubMed)

Lalain M, Ghio A, Giusti L, Robert D, Fredouille C, Woisard V. Design and Development of a Speech Intelligibility Test Based on Pseudowords in French: Why and How? J Speech Lang Hear Res. 2020 Jul 20;63(7):2070-2083. doi: 10.1044/2020_JSLHR-19-00088. Epub 2020 Jun 29.

Reference Type: BACKGROUND

PMID: 32598209 (View on PubMed)

Other Identifiers

2020-A02335-34

Identifier Type: OTHER

Identifier Source: secondary_id

RC31/20/0551

Identifier Type: -

Identifier Source: org_study_id